NASDAQ: GDTCCytomed Therapeutics Ltd Stock Ownership - Who owns Cytomed Therapeutics?
Insider buying vs selling
Have Cytomed Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GDTC insiders and whales buy or sell their stock.
GDTC Shareholders
What type of owners hold Cytomed Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Glorious Finance Ltd | 40.33% | 4,653,604 | $4.93M | Insider |
| Shu Wang | 7.66% | 883,858 | $936.89k | Insider |
| Jieming Zeng | 5.11% | 589,239 | $624.59k | Insider |
| Chee Kong Choo | 3.56% | 410,515 | $435.15k | Insider |
| Lucas Tien Wee Luk | 0.80% | 92,563 | $98.12k | Insider |
| Susquehanna International Group LLP | 0.26% | 29,829 | $31.62k | Institution |
| Two Sigma Securities LLC | 0.10% | 11,857 | $12.57k | Institution |
| Stonex Group Inc | 0.09% | 10,356 | $10.98k | Institution |
| Ubs Group Ag | 0.01% | 1,065 | $1.13k | Institution |
| Osaic Holdings Inc | 0.00% | 21 | $22.26 | Institution |
GDTC vs Biotech Stocks
Cytomed Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.